questionsmedicales.fr
Composés chimiques organiques
Amines
Éthylamines
Phénéthylamines
Isoxsuprine
Isoxsuprine : Questions médicales fréquentes
Diagnostic
2
Vasodilatateurs
Troubles circulatoires
Circulation sanguine
Évaluation clinique
Symptômes
2
Douleurs aux jambes
Circulation sanguine
Effets secondaires
Nausées
Prévention
2
Exercice physique
Alimentation saine
Traitements
2
Administration orale
Voie intraveineuse
Posologie
Traitement médicamenteux
Complications
2
Réactions allergiques
Troubles cardiaques
Gestion des complications
Consultation médicale
Facteurs de risque
2
Antécédents médicaux
Maladies cardiaques
Âge
Sensibilité médicamenteuse
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Isoxsuprine : Questions médicales les plus fréquentes",
"headline": "Isoxsuprine : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Isoxsuprine : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-05",
"dateModified": "2026-04-25",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Isoxsuprine"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Phénéthylamines",
"url": "https://questionsmedicales.fr/mesh/D010627",
"about": {
"@type": "MedicalCondition",
"name": "Phénéthylamines",
"code": {
"@type": "MedicalCode",
"code": "D010627",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.092.471.683"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Isoxsuprine",
"alternateName": "Isoxsuprine",
"code": {
"@type": "MedicalCode",
"code": "D007556",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Somaye Shahraki",
"url": "https://questionsmedicales.fr/author/Somaye%20Shahraki",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, University of Zabol, Zabol, Iran. Electronic address: s-shahraki@uoz.ac.ir."
}
},
{
"@type": "Person",
"name": "Hojat Samareh Delarami",
"url": "https://questionsmedicales.fr/author/Hojat%20Samareh%20Delarami",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, University of Zabol, Zabol, Iran."
}
},
{
"@type": "Person",
"name": "Maryam Saeidifar",
"url": "https://questionsmedicales.fr/author/Maryam%20Saeidifar",
"affiliation": {
"@type": "Organization",
"name": "Department of Nanotechnology and Advanced Materials, Materials and Energy Research Center, Karaj, Iran."
}
},
{
"@type": "Person",
"name": "Razieh Nejat",
"url": "https://questionsmedicales.fr/author/Razieh%20Nejat",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, Kosar University of Bojnord, Bojnord, Iran."
}
},
{
"@type": "Person",
"name": "Namrata Ray",
"url": "https://questionsmedicales.fr/author/Namrata%20Ray",
"affiliation": {
"@type": "Organization",
"name": "Department of Obstetrics and Gynecology, Krishna Institute of Medical Sciences, Karad, Maharashtra, India."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Effects of topical isoxsuprine ointment on imiquimod-induced psoriasiform skin inflammation in mice.",
"datePublished": "2024-08-08",
"url": "https://questionsmedicales.fr/article/39115559",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00210-024-03359-2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Development of a New Isoxsuprine Hydrochloride-Based Hydroxylated Compound with Potent Antioxidant and Anti-Inflammatory Activities.",
"datePublished": "2024-10-03",
"url": "https://questionsmedicales.fr/article/39467698",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.4014/jmb.2405.05031"
}
},
{
"@type": "ScholarlyArticle",
"name": "Formulation and Therapeutic Evaluation of Isoxsuprine-Loaded Nanoparticles against Diabetes-Associated Stroke.",
"datePublished": "2023-08-30",
"url": "https://questionsmedicales.fr/article/37765211",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/pharmaceutics15092242"
}
},
{
"@type": "ScholarlyArticle",
"name": "Catalytic activity and structural changes of catalase in the presence of Levothyroxine and Isoxsuprine hydrochloride.",
"datePublished": "2020-02-08",
"url": "https://questionsmedicales.fr/article/32045611",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ijbiomac.2020.02.064"
}
},
{
"@type": "ScholarlyArticle",
"name": "Oral nifedipine and parenteral isoxsuprine in arresting preterm labor: A comparative study.",
"datePublished": "2022-05-14",
"url": "https://questionsmedicales.fr/article/35800477",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.4103/jfmpc.jfmpc_1696_20"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés chimiques organiques",
"item": "https://questionsmedicales.fr/mesh/D009930"
},
{
"@type": "ListItem",
"position": 3,
"name": "Amines",
"item": "https://questionsmedicales.fr/mesh/D000588"
},
{
"@type": "ListItem",
"position": 4,
"name": "Éthylamines",
"item": "https://questionsmedicales.fr/mesh/D005021"
},
{
"@type": "ListItem",
"position": 5,
"name": "Phénéthylamines",
"item": "https://questionsmedicales.fr/mesh/D010627"
},
{
"@type": "ListItem",
"position": 6,
"name": "Isoxsuprine",
"item": "https://questionsmedicales.fr/mesh/D007556"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Isoxsuprine - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Isoxsuprine",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-05-04",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Isoxsuprine",
"description": "Comment l'isoxsuprine est-elle diagnostiquée ?\nQuels tests sont utilisés pour évaluer l'efficacité de l'isoxsuprine ?",
"url": "https://questionsmedicales.fr/mesh/D007556#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Isoxsuprine",
"description": "Quels symptômes l'isoxsuprine traite-t-elle ?\nL'isoxsuprine peut-elle provoquer des effets secondaires ?",
"url": "https://questionsmedicales.fr/mesh/D007556#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Isoxsuprine",
"description": "L'isoxsuprine est-elle utilisée en prévention ?\nQuelles mesures préventives sont recommandées ?",
"url": "https://questionsmedicales.fr/mesh/D007556#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Isoxsuprine",
"description": "Comment l'isoxsuprine est-elle administrée ?\nQuelle est la posologie standard de l'isoxsuprine ?",
"url": "https://questionsmedicales.fr/mesh/D007556#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Isoxsuprine",
"description": "Quelles complications peuvent survenir avec l'isoxsuprine ?\nComment gérer les complications de l'isoxsuprine ?",
"url": "https://questionsmedicales.fr/mesh/D007556#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Isoxsuprine",
"description": "Quels sont les facteurs de risque pour l'utilisation de l'isoxsuprine ?\nL'âge influence-t-il l'utilisation de l'isoxsuprine ?",
"url": "https://questionsmedicales.fr/mesh/D007556#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment l'isoxsuprine est-elle diagnostiquée ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'isoxsuprine n'est pas un diagnostic, mais un traitement pour des troubles circulatoires."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'efficacité de l'isoxsuprine ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de circulation sanguine et des évaluations cliniques sont utilisés."
}
},
{
"@type": "Question",
"name": "Quels symptômes l'isoxsuprine traite-t-elle ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle traite les symptômes liés à une mauvaise circulation, comme les douleurs aux jambes."
}
},
{
"@type": "Question",
"name": "L'isoxsuprine peut-elle provoquer des effets secondaires ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des effets secondaires comme des nausées ou des palpitations peuvent survenir."
}
},
{
"@type": "Question",
"name": "L'isoxsuprine est-elle utilisée en prévention ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle n'est pas utilisée en prévention, mais pour traiter des symptômes existants."
}
},
{
"@type": "Question",
"name": "Quelles mesures préventives sont recommandées ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des exercices réguliers et une alimentation saine sont conseillés pour la circulation."
}
},
{
"@type": "Question",
"name": "Comment l'isoxsuprine est-elle administrée ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle est généralement administrée par voie orale ou intraveineuse selon la condition."
}
},
{
"@type": "Question",
"name": "Quelle est la posologie standard de l'isoxsuprine ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "La posologie varie, mais elle est souvent de 5 à 10 mg trois fois par jour."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec l'isoxsuprine ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications rares incluent des réactions allergiques ou des troubles cardiaques."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications de l'isoxsuprine ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est essentiel de consulter un médecin pour ajuster le traitement ou les doses."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour l'utilisation de l'isoxsuprine ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents de maladies cardiaques ou d'allergies peuvent être des facteurs de risque."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il l'utilisation de l'isoxsuprine ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées peuvent être plus sensibles aux effets de l'isoxsuprine."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 25/04/2026
Contenu vérifié selon les dernières recommandations médicales
1 publication dans cette catégorie
Affiliations :
Department of Chemistry, University of Zabol, Zabol, Iran. Electronic address: s-shahraki@uoz.ac.ir.
Publications dans "Isoxsuprine" :
1 publication dans cette catégorie
Affiliations :
Department of Chemistry, University of Zabol, Zabol, Iran.
Publications dans "Isoxsuprine" :
1 publication dans cette catégorie
Affiliations :
Department of Nanotechnology and Advanced Materials, Materials and Energy Research Center, Karaj, Iran.
Publications dans "Isoxsuprine" :
1 publication dans cette catégorie
Affiliations :
Department of Chemistry, Kosar University of Bojnord, Bojnord, Iran.
Publications dans "Isoxsuprine" :
1 publication dans cette catégorie
Affiliations :
Department of Obstetrics and Gynecology, Krishna Institute of Medical Sciences, Karad, Maharashtra, India.
Publications dans "Isoxsuprine" :
1 publication dans cette catégorie
Affiliations :
Department of Obstetrics and Gynecology, Krishna Institute of Medical Sciences, Karad, Maharashtra, India.
Publications dans "Isoxsuprine" :
1 publication dans cette catégorie
Affiliations :
Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Merit University (MUE), Sohag 1646080, Egypt.
Publications dans "Isoxsuprine" :
1 publication dans cette catégorie
Affiliations :
Department of Pharmaceutics, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia.
Publications dans "Isoxsuprine" :
1 publication dans cette catégorie
Affiliations :
Department of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, P.O. Box 173, Al-Kharj 11942, Saudi Arabia.
Department of Pharmaceutics and Industrial Pharmacy, College of Pharmacy, Beni-Suef University, Beni-Suef 62514, Egypt.
Publications dans "Isoxsuprine" :
1 publication dans cette catégorie
Affiliations :
Department of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam Bin Abdulaziz University, P.O. Box 173, Al-Kharj 11942, Saudi Arabia.
Publications dans "Isoxsuprine" :
1 publication dans cette catégorie
Affiliations :
Department of Pharmaceutics, College of Pharmacy, Umm Al Qura University, Makkah 21421, Saudi Arabia.
Publications dans "Isoxsuprine" :
1 publication dans cette catégorie
Affiliations :
Department of Pharmacology, Faculty of Medicine, Beni-Suef University, Beni-Suef 62511, Egypt.
Publications dans "Isoxsuprine" :
1 publication dans cette catégorie
Affiliations :
Department of Pharmacology, Faculty of Veterinary Medicine, Beni-Suef University, Beni-Suef 62511, Egypt.
Publications dans "Isoxsuprine" :
1 publication dans cette catégorie
Affiliations :
Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Beni-Suef University, Beni-Suef 62514, Egypt.
Publications dans "Isoxsuprine" :
1 publication dans cette catégorie
Affiliations :
Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Beni-Suef University, Beni-Suef 62514, Egypt.
Publications dans "Isoxsuprine" :
1 publication dans cette catégorie
Affiliations :
Bahri Dağdaş International Agricultural Research Intitute, Ereğli St. No 10Y Karatay / Konya, Türki̇ye.
Publications dans "Isoxsuprine" :
1 publication dans cette catégorie
Affiliations :
Bahri Dağdaş International Agricultural Research Intitute, Ereğli St. No 10Y Karatay / Konya, Türki̇ye.
Publications dans "Isoxsuprine" :
1 publication dans cette catégorie
Affiliations :
Department of Pharmacology, College of Medicine, Al-Nahrain University, Baghdad, Iraq.
Publications dans "Isoxsuprine" :
1 publication dans cette catégorie
Affiliations :
Department of Pharmacology, College of Medicine, University of Warith Al-Anbiyaa, Karbala, Iraq.
Publications dans "Isoxsuprine" :
1 publication dans cette catégorie
Affiliations :
Department of Medicine, College of Medicine, Al-Nahrain University, Baghdad, Iraq.
Publications dans "Isoxsuprine" :
This study assesses the potential positive impact of a 0.05% isoxsuprine ointment on psoriasiform skin inflammation generated by imiquimod in mouse models. Thirty-two male albino mice were allocated i...
The scientific community actively pursuits novel compounds with biological activities. In this context, our study utilized the predicted data mining approach (PDMA), which can efficiently screen out b...
Ischemic stroke is the second-leading cause of death. Hyperglycemia, which is characteristic of diabetes mellitus, contributes to the development of endothelial dysfunction and increases the risk of s...
Two drugs that pregnant women (with hypothyroidism) may use during pregnancy include Isoxsuprine hydrochloride (ISO) and levothyroxine (LEV); ISO to reduce uterine contractions and LEV for the treatme...
To compare the efficacy of oral nifedipine and parenteral isoxsuprine in arresting preterm labor. Considering the paucity of studies comparing these two agents, a comparative analysis is obligatory....
Eighty antenatal women in the gestational age range of 28-37 weeks, with regular uterine contractions, cervical dilatation ≤3 cm, and <50% cervical effacement, admitted with complaints of preterm labo...
Isoxsuprine showed increased lowering of systolic blood pressure (SBP), diastolic blood pressure (DBP), and slightly higher maternal pulse rate, but higher fetal pulse rate post-administration in comp...
Nifedipine was slightly more effective in arresting preterm labor with fewer side effects, compared to isoxsuprine....
The aim of the study is to obtain insights on the short and long-term safety and effectiveness of isoxsuprine hydrochloride as a tocolytic agent in the management of PTL....
In this prospective, single-center, noncomparative study, patients (with preterm labor at gestational age of 24-37 weeks) were administered intravenous (IV) infusion of 40-mg isoxsuprine hydrochloride...
All patients (...
Isoxsuprine was found to be an effective and well-tolerated tocolytic agent in arresting PTL, in turn resulting in the overall improvement in maternal and perinatal outcomes....
Isoxsuprine (ISX) is widely used for cerebral and peripheral vascular diseases. A comparative study was held among different multivariate calibration models for selective determination of a complex mi...
Recently, our research group demonstrated that uvaol and ursolic acid increase NO and H₂S production in aortic tissue. Molecular docking studies showed that both compounds bind with high affinity to e...